Uptake of biosimilars for TNF-α inhibitors adalimumab and etanercept following the best-value biological medicine initiative in Ireland
Crossref DOI link: https://doi.org/10.1007/s11096-021-01243-0
Published Online: 2021-02-09
Published Print: 2021-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Duggan, B.
Smith, Amelia http://orcid.org/0000-0003-3070-2268
Barry, M.
Text and Data Mining valid from 2021-02-09
Version of Record valid from 2021-02-09
Article History
Received: 31 August 2020
Revised: 19 January 2021
Accepted: 21 January 2021
First Online: 9 February 2021